Agenus: Pivot To Neoadjuvant Setting In CRC Sends Stock Soaring - But Caution Advised

SignalsMonitor is following this as a markets story. Seeking Alpha is the outlet attached so far. The first report grouped here was at 29 Sept 2026, 15:38 UTC. The headline in use is “Agenus: Pivot To Neoadjuvant Setting In CRC Sends Stock Soaring - But Caution Advised”. This note is SignalsMonitor's own briefing, not the publisher's article.